Inicio › Carcinoma de células escamosas de cabeza y cuello › South Carolina › Charleston
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Charleston, SC
14 estudios para Carcinoma de células escamosas de cabeza y cuello buscan participantes en centros de Charleston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
ReclutandoFase 2/3
- Site#0104, Charleston
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
ReclutandoFase 3
- Medical University of South Carolina, Charleston
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
ReclutandoFase 2
- Medical University of South Carolina, Charleston
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
ReclutandoFase 2
- Medical University of South Carolina, Charleston
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Charleston
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
ReclutandoFase 2/3
- Medical University of South Carolina, Charleston
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
ReclutandoFase 2
- Medical University of South Carolina Hollings Cancer Center, Charleston
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
ReclutandoFase 3
- GSK Investigational Site, Charleston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
ReclutandoFase 2
- USA03-0, Charleston
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
ReclutandoFase 2
- Medical University of South Carolina, Charleston
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
ReclutandoFase 3
- Medical University of South Carolina (MUSC), Charleston
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Reclutando
- Medical University of South Carolina, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site 123, Charleston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
ReclutandoFase 1
- Medical University of South Carolina, Hollings Cancer Center, Charleston
Ensayos de Carcinoma de células escamosas de cabeza y cuello en otras ciudades
- Houston, TX47 estudios
- Los Angeles, CA42 estudios
- Boston, MA40 estudios
- Nashville, TN39 estudios
- New York City, NY39 estudios
- St. Louis, MO28 estudios
- Arlington, VA26 estudios
- Chicago, IL26 estudios
- Philadelphia, PA26 estudios
- Atlanta, GA24 estudios
- San Antonio, TX22 estudios
- Pittsburgh, PA22 estudios
Otros estudios en Charleston
- Depresión19 estudios
- Accidente cerebrovascular18 estudios
- Fallo cardíaco18 estudios
- Cáncer de pulmón de células no pequeñas16 estudios
- Trastorno de estrés postraumático16 estudios
- Enfermedad cardiovascular15 estudios
- Cáncer de próstata15 estudios
- Cáncer (todos los tipos)14 estudios
- Enfermedad de Parkinson13 estudios
- Enfermedad pulmonar intersticial13 estudios
- Cáncer de seno12 estudios
- Cáncer de pulmón11 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.